Quality control guidelines for amphotericin B, itraconazole, posaconazole, and voriconazole disk diffusion susceptibility tests with nonsupplemented Mueller-Hinton agar (CLSI M51-A document) for nondermatophyte filamentous fungi

Journal of Clinical Microbiology

Volumn 49, Issue 7, 2011, Pages 2568-2571

  Espinel Ingroff, A ^a   Canton, E ^b   Fothergill, A ^c   Ghannoum, M ^d   Johnson, E ^e   Jones, R N ^f   Ostrosky Zeichner, L ^g   Schell, W ^h   Gibbs, D L ⁱ   Wang, A ⁱ   Turnidge, J ^j,k  

^a VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e HPA Centre for Infections   (United Kingdom)

^f JMI LABORATORIES   (United States)

^g UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^h DUKE UNIVERSITY MEDICAL CENTER   (United States)

ⁱ Giles Scientific Inc   (United States)

^j WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^k UNIVERSITY OF ADELAIDE   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ITRACONAZOLE; POSACONAZOLE; VORICONAZOLE;

AGAR MEDIUM; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS TERREUS; CANDIDA KRUSEI; CONTROLLED STUDY; DISK DIFFUSION; FUNGAL STRAIN; FUNGUS ISOLATION; FUSARIUM MONILIFORME; NONHUMAN; PAECILOMYCES; PAECILOMYCES VARIOTII; PRIORITY JOURNAL; QUALITY CONTROL; REPRODUCIBILITY;

ANTIFUNGAL AGENTS; CULTURE MEDIA; FUNGI; MICROBIAL SENSITIVITY TESTS; MYCOLOGY; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS;

ASPERGILLUS FUMIGATUS; FUNGI; GIBBERELLA MONILIFORMIS; ISSATCHENKIA ORIENTALIS; PAECILOMYCES VARIOTII;

EID: 79959842926     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00393-11     Document Type: Article

References (11)

1. Barry, A. L., et al. 2000. Quality control limits for broth microdilution susceptibility tests of ten antifungal agents. J. Clin. Microbiol. 38:3457-3459.
2. Clinical and Laboratory Standards Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard, 2nd ed. CLSI document M38-A2. Clinical and Laboratory Standards Institute, Villanova, PA.
3. Clinical and Laboratory Standards Institute. 2008. Development of in vitro susceptibility testing criteria and quality control parameters; approved guideline, 3rd ed. CLSI document M23-A3. Clinical and Laboratory Standards Institute, Villanova, PA.
4. Clinical and Laboratory Standards Institute. 2009. Zone diameter interpretive standards, corresponding minimal inhibitory concentration (MIC) interpretive breakpoints, and quality control limits for antifungal disk diffusion susceptibility testing of yeasts; informational supplement, 3rd ed. CLSI document M44-S3. Clinical and Laboratory Standards Institute, Villanova, PA.
5. Clinical and Laboratory Standards Institute. 2010. Reference method for antifungal disk diffusion susceptibility testing of non-dermatophyte filamentous fungi; approved guideline. CLSI document M51-A. Clinical and Laboratory Standards Institute, Villanova, PA.
6. Clinical and Laboratory Standards Institute. 2010. Performance standards for antifungal disk diffusion susceptibility testing of non-dermatophyte filamentous fungi; Informational supplement, 1st ed. CLSI document M51-A. Clinical and Laboratory Standards Institute, Villanova, PA.
7. Espinel-Ingroff, A., et al. 1997. Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi. J. Clin. Microbiol. 35:139-143.
8. Espinel-Ingroff, A., et al. 2001. Optimal susceptibility testing conditions for detection of azole resistance in Aspergillus spp.: NCCLS collaborative evaluation. Antimicrob. Agents Chemother. 45:1828-1835.
9. Espinel-Ingroff, A., et al. 2007. Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B and caspofungin. J. Clin. Microbiol. 45:1811-1820.
10. Gavan, T. L., et al. 1981. Quality control limits for ampicillin, carbenicillin, mezlocillin, and piperacillin disk diffusion susceptibility tests: a collaborative study. J. Clin. Microbiol. 14:67-72.
11. Turnidge, J., and G. Bordash. 2007. Statistical method for establishing quality control ranges for antibacterial agents in Clinical and Laboratory Standards Institute susceptibility testing. Antimicrob. Agents Chemother. 51:2483-2488.